• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

秘鲁未接种新冠病毒疫苗加强针的相关因素。

Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru.

作者信息

Bendezu-Quispe Guido, Caira-Chuquineyra Brenda, Fernandez-Guzman Daniel, Urrunaga-Pastor Diego, Herrera-Añazco Percy, Benites-Zapata Vicente A

机构信息

Escuela de Medicina, Universidad César Vallejo, Trujillo 13001, Peru.

Facultad de Medicina, Universidad Nacional de San Agustín, Arequipa 04001, Peru.

出版信息

Vaccines (Basel). 2022 Jul 26;10(8):1183. doi: 10.3390/vaccines10081183.

DOI:10.3390/vaccines10081183
PMID:35893832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9330573/
Abstract

To determine the factors associated with not receiving the booster dose for COVID-19 in Peru, a cross-sectional study by secondary analysis of a University of Maryland and Facebook survey database assessing the global impact of COVID-19 was conducted. Data of Peruvian users of this social network over 18 years of age who answered the survey between 13 February 2022 and 14 April 2022 were analyzed. We evaluated the association between sociodemographic characteristics, comorbidities, and history of COVID-19 with having received a booster dose for COVID-19. Crude (cPR) and adjusted (aPR) prevalence ratios with their respective 95% confidence intervals (95%CI) were calculated. A sample of 20,814 adults, 21.5% of whom reported not receiving the booster dose, was analyzed. People under 75 years of age had a higher prevalence of not having received the booster dose. Likewise, having a university education (aPR = 1.03; 95%CI: 1.02-1.05), secondary, or pre-university education (aPR = 1.07; 95%CI: 1.05-1.09), or having a primary level or less (aPR = 1.11; 95%CI: 1.05-1.18), were associated with a higher prevalence of not receiving the booster, compared to individuals with a postgraduate education. Being employed (aPR = 1.01; 95%CI: 1.00-1.02), having had COVID-19 (aPR = 1.03; 95%CI: 1.01-1.04) and living in a town (aPR = 1.05; 95%CI: 1.02-1.07) or in a rural area (aPR = 1.06; 95%CI: 1.03-1.10), compared to living in the city, had a similar association. On the contrary, the female gender was associated with a lower prevalence of not receiving the booster (aPR = 0.97; 95%CI: 0.96-0.99). Sociodemographic characteristics and a history of having had COVID-19 were associated with the probability of not having received the booster dose for COVID-19 in the Peruvian population.

摘要

为了确定秘鲁未接种新冠病毒加强针的相关因素,我们对马里兰大学和脸书的一项评估新冠病毒全球影响的调查数据库进行二次分析,开展了一项横断面研究。分析了2022年2月13日至2022年4月14日期间回答该调查的18岁以上秘鲁脸书用户的数据。我们评估了社会人口学特征、合并症和新冠病毒感染史与接种新冠病毒加强针之间的关联。计算了粗患病率比(cPR)和调整患病率比(aPR)及其各自的95%置信区间(95%CI)。分析了20814名成年人的样本,其中21.5%的人报告未接种加强针。75岁以下人群未接种加强针的患病率更高。同样,与研究生学历的人相比,拥有大学学历(aPR = 1.03;95%CI:1.02 - 1.05)、高中学历或大学预科(aPR = 1.07;95%CI:1.05 - 1.09)或小学及以下学历(aPR = 1.11;95%CI:1.05 - 1.18)的人未接种加强针的患病率更高。与居住在城市相比,就业(aPR = 1.01;95%CI:1.00 - 1.02)、感染过新冠病毒(aPR = 1.03;95%CI:1.01 - 1.04)以及居住在城镇(aPR = 1.05;95%CI:1.02 - 1.07)或农村地区(aPR = 1.06;95%CI:1.03 - 1.10)有类似的关联。相反,女性未接种加强针的患病率较低(aPR = 0.97;95%CI:0.96 - 0.99)。社会人口学特征和新冠病毒感染史与秘鲁人群未接种新冠病毒加强针的可能性相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58bf/9330573/1f6c6a12c274/vaccines-10-01183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58bf/9330573/1f6c6a12c274/vaccines-10-01183-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58bf/9330573/1f6c6a12c274/vaccines-10-01183-g001.jpg

相似文献

1
Factors Associated with Not Receiving a Booster Dose of COVID-19 Vaccine in Peru.秘鲁未接种新冠病毒疫苗加强针的相关因素。
Vaccines (Basel). 2022 Jul 26;10(8):1183. doi: 10.3390/vaccines10081183.
2
Prevalence and factors associated with not receiving the booster dose of the COVID-19 vaccine in adults in Latin America and the Caribbean.拉丁美洲和加勒比地区成年人未接种 COVID-19 疫苗加强针的流行情况及相关因素。
Travel Med Infect Dis. 2022 Nov-Dec;50:102409. doi: 10.1016/j.tmaid.2022.102409. Epub 2022 Aug 9.
3
Factors associated with intention to be vaccinated with the COVID-19 booster dose: a cross-sectional study in Peru.与接种 COVID-19 加强针意愿相关的因素:秘鲁的一项横断面研究。
PeerJ. 2024 Mar 29;12:e16727. doi: 10.7717/peerj.16727. eCollection 2024.
4
Geographic, Occupational, and Sociodemographic Variations in Uptake of COVID-19 Booster Doses Among Fully Vaccinated US Adults, December 1, 2021, to January 10, 2022.2021 年 12 月 1 日至 2022 年 1 月 10 日期间,完全接种疫苗的美国成年人中 COVID-19 加强剂量的接种率在地域、职业和社会人口统计学方面的差异。
JAMA Netw Open. 2022 Aug 1;5(8):e2227680. doi: 10.1001/jamanetworkopen.2022.27680.
5
Prevalence of parents' non-intention to vaccinate their children and adolescents against COVID-19: A comparative analysis in Colombia and Peru.父母无意为其子女和青少年接种新冠疫苗的情况:哥伦比亚和秘鲁的比较分析
Vaccine X. 2022 Jul 27;12:100198. doi: 10.1016/j.jvacx.2022.100198. eCollection 2022 Dec.
6
Factors associated with not receiving the primary series and booster dose of the COVID-19 vaccine among Venezuelan migrants in Peru: A population-based cross-sectional study.秘鲁委内瑞拉移民未接种 COVID-19 疫苗初级系列和加强针的相关因素:基于人群的横断面研究。
Travel Med Infect Dis. 2023 May-Jun;53:102563. doi: 10.1016/j.tmaid.2023.102563. Epub 2023 Mar 9.
7
Prevalence and factors associated with non-use of health services in the Peruvian population with COVID-19 symptomatology: a secondary analysis of the 2020 National Household Survey.COVID-19 症状秘鲁人群中未使用卫生服务的流行情况及相关因素:2020 年全国家庭调查的二次分析。
Epidemiol Health. 2021;43:e2021084. doi: 10.4178/epih.e2021084. Epub 2021 Oct 18.
8
Chronic disease relapses: A cross-sectional study of the associated factors and socioeconomic inequalities during the COVID-19 pandemic in Peru.慢性疾病复发:秘鲁 COVID-19 大流行期间相关因素和社会经济不平等的横断面研究。
PLoS One. 2022 Sep 16;17(9):e0274697. doi: 10.1371/journal.pone.0274697. eCollection 2022.
9
Factors associated with the consumption of chlorine dioxide to prevent and treat COVID-19 in the Peruvian population: a cross-sectional study.与秘鲁人群中使用二氧化氯预防和治疗 COVID-19 相关的因素:一项横断面研究。
BMC Public Health. 2021 Nov 17;21(1):2109. doi: 10.1186/s12889-021-12191-9.
10
Sociodemographic factors associated with immediate puerperal control: A cross-sectional study based on the Peruvian demographic and health survey, 2019.与产后即刻避孕相关的社会人口学因素:基于2019年秘鲁人口与健康调查的横断面研究
Eur J Obstet Gynecol Reprod Biol X. 2023 Oct 12;20:100253. doi: 10.1016/j.eurox.2023.100253. eCollection 2023 Dec.

引用本文的文献

1
Association between self-administrated prophylactics and SARS-CoV-2 infection among traditional market vendors from the Central Highlands of Peru: A nested case-control study.秘鲁中部高地传统市场摊贩自行使用预防措施与感染严重急性呼吸综合征冠状病毒2之间的关联:一项巢式病例对照研究。
PLoS One. 2025 Jul 11;20(7):e0327746. doi: 10.1371/journal.pone.0327746. eCollection 2025.
2
Using regression tree analysis to examine demographic and geographic characteristics of COVID-19 vaccination trends over time, United States, May 2021-April 2022, National Immunization Survey Adult COVID Module.利用回归树分析研究2021年5月至2022年4月美国全国免疫调查成人新冠模块中随时间变化的新冠疫苗接种趋势的人口统计学和地理特征。
Vaccine. 2024 Dec 2;42(26):126372. doi: 10.1016/j.vaccine.2024.126372. Epub 2024 Oct 4.
3

本文引用的文献

1
Global impact of the first year of COVID-19 vaccination: a mathematical modelling study.全球首例 COVID-19 疫苗接种一年的影响:一项数学建模研究。
Lancet Infect Dis. 2022 Sep;22(9):1293-1302. doi: 10.1016/S1473-3099(22)00320-6. Epub 2022 Jun 23.
2
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.同源和异源加强针对于灭活 SARS-CoV-2 疫苗的有效性:一项大规模前瞻性队列研究。
Lancet Glob Health. 2022 Jun;10(6):e798-e806. doi: 10.1016/S2214-109X(22)00112-7. Epub 2022 Apr 23.
3
Gender Differences in Depressive and Anxiety Symptoms During the First Stage of the COVID-19 Pandemic: A Cross-Sectional Study in Latin America and the Caribbean.
Trends in Intention to Take the Second Booster COVID-19 Vaccination and Associated Factors in China: Serial Cross-Sectional Surveys.中国接种新冠病毒疫苗第二剂加强针的意愿趋势及相关因素:系列横断面调查
Vaccines (Basel). 2024 May 7;12(5):502. doi: 10.3390/vaccines12050502.
4
Global disparities in COVID-19 vaccine booster dose (VBD) acceptance and hesitancy: An updated narrative review.全球新冠疫苗加强针接种接受度与犹豫情况的差异:最新叙述性综述
Vaccine X. 2024 Mar 23;18:100480. doi: 10.1016/j.jvacx.2024.100480. eCollection 2024 Jun.
5
Impact of prior SARS-CoV-2 infection on college students' hesitancy to receive additional COVID-19 vaccine booster doses: A study from Taizhou, China.既往感染严重急性呼吸综合征冠状病毒2对大学生接种额外新冠病毒疫苗加强针的犹豫态度的影响:一项来自中国台州的研究。
Prev Med Rep. 2024 Mar 29;41:102709. doi: 10.1016/j.pmedr.2024.102709. eCollection 2024 May.
6
Factors associated with intention to be vaccinated with the COVID-19 booster dose: a cross-sectional study in Peru.与接种 COVID-19 加强针意愿相关的因素:秘鲁的一项横断面研究。
PeerJ. 2024 Mar 29;12:e16727. doi: 10.7717/peerj.16727. eCollection 2024.
7
Acceptance of COVID-19 vaccine booster dose among the people of Bangladesh: A cross-sectional study.孟加拉国人群对新冠病毒疫苗加强针的接受情况:一项横断面研究。
Heliyon. 2023 Nov 11;9(11):e22215. doi: 10.1016/j.heliyon.2023.e22215. eCollection 2023 Nov.
8
Geographic and Socioeconomic Determinants of Full Coverage COVID-19 Vaccination in Peru: Findings from a National Population-Based Study.秘鲁新冠疫苗全程接种的地理和社会经济决定因素:一项基于全国人口研究的结果
Vaccines (Basel). 2023 Jul 3;11(7):1195. doi: 10.3390/vaccines11071195.
9
Public Knowledge About COVID-19 Booster Vaccines in Pakistan: A Study Conducted in a Tertiary Care Hospital in Karachi.巴基斯坦公众对新冠病毒加强疫苗的认知:在卡拉奇一家三级医疗医院开展的一项研究
Cureus. 2023 Jun 12;15(6):e40284. doi: 10.7759/cureus.40284. eCollection 2023 Jun.
10
Multi-dimensional potential factors influencing COVID-19 vaccine booster acceptance and hesitancy among university academic community in Bangladesh: A cross-sectional comparative study.多维度潜在因素影响孟加拉国大学学术界对 COVID-19 疫苗加强针的接受度和犹豫:一项横断面比较研究。
PLoS One. 2023 Apr 13;18(4):e0281395. doi: 10.1371/journal.pone.0281395. eCollection 2023.
新冠疫情第一阶段抑郁和焦虑症状的性别差异:拉丁美洲和加勒比地区的一项横断面研究
Front Psychiatry. 2022 Mar 17;13:727034. doi: 10.3389/fpsyt.2022.727034. eCollection 2022.
4
Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine.BNT162b2 新冠病毒疫苗第三剂的安全性和有效性。
N Engl J Med. 2022 May 19;386(20):1910-1921. doi: 10.1056/NEJMoa2200674. Epub 2022 Mar 23.
5
Association of Non-Pharmaceutical Interventions to Reduce the Spread of SARS-CoV-2 With Anxiety and Depressive Symptoms: A Multi-National Study of 43 Countries.非药物干预措施对减少 SARS-CoV-2 传播与焦虑和抑郁症状的相关性:多国 43 个国家的研究。
Int J Public Health. 2022 Mar 3;67:1604430. doi: 10.3389/ijph.2022.1604430. eCollection 2022.
6
Excess all-cause deaths stratified by sex and age in Peru: a time series analysis during the COVID-19 pandemic.秘鲁按性别和年龄分层的全因超额死亡人数:COVID-19 大流行期间的时间序列分析。
BMJ Open. 2022 Mar 10;12(3):e057056. doi: 10.1136/bmjopen-2021-057056.
7
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.疫苗预防严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染和 COVID-19 疾病有效性的持续时间:系统评价和荟萃回归的结果。
Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23.
8
Effectiveness of COVID-19 booster vaccines against COVID-19-related symptoms, hospitalization and death in England.英格兰 COVID-19 加强疫苗对与 COVID-19 相关症状、住院和死亡的有效性。
Nat Med. 2022 Apr;28(4):831-837. doi: 10.1038/s41591-022-01699-1. Epub 2022 Jan 14.
9
Prevalence and factors associated with the intention to be vaccinated against COVID-19 in Peru.秘鲁 COVID-19 疫苗接种意愿的流行率及相关因素。
Rev Peru Med Exp Salud Publica. 2021 Jul-Sep;38(3):381-390. doi: 10.17843/rpmesp.2021.383.7446. Epub 2021 Dec 20.
10
COVID-19 symptomatology and compliance with community mitigation strategies in Latin America early during the COVID-19 pandemic.COVID-19大流行早期拉丁美洲的COVID-19症状及社区缓解策略的依从情况。
Prev Med Rep. 2022 Feb;25:101665. doi: 10.1016/j.pmedr.2021.101665. Epub 2021 Dec 10.